Esperite (voorheen Cryo Save) « Terug naar discussie overzicht

Nepnieuws van Amar/Esperite

14 Posts
DeZwarteRidder
0
Company press releases
Displaying 21 - 40 of 110 results
Released Company Title Industry Topic
01 Jul 2019
07:17 CEST ESPERITE
ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
Biotechnology Alliances and agreements
30 Jun 2019
21:01 CEST ESPERITE
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
Biotechnology New
28 Jun 2019
23:51 CEST ESPERITE
Esperite N.V.: Update to the market on the publication of the Annual Report 2018
Biotechnology New
25 Jun 2019
22:59 CEST ESPERITE
ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
Biotechnology Other subject
14 Jun 2019
08:54 CEST ESPERITE
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
Biotechnology Other subject
13 Jun 2019
07:17 CEST ESPERITE
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
Biotechnology Other subject
04 Jun 2019
10:18 CEST ESPERITE
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
Biotechnology Other subject
29 May 2019
08:26 CEST ESPERITE
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
Biotechnology Other subject
19 May 2019
22:54 CEST ESPERITE
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
Biotechnology Other subject
13 May 2019
07:17 CEST ESPERITE
Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
Biotechnology Other subject
01 May 2019
16:58 CEST ESPERITE
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018
Biotechnology Other subject
05 Apr 2019
07:17 CEST ESPERITE
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
Biotechnology Other subject
27 Feb 2019
07:17 CET ESPERITE
Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
Biotechnology Other subject
26 Feb 2019
07:17 CET ESPERITE
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
Biotechnology Other subject
22 Feb 2019
07:17 CET ESPERITE
ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
Biotechnology Other subject
10 Jan 2019
07:17 CET ESPERITE
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
Biotechnology Other subject
30 Nov 2018
07:17 CET ESPERITE
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today
Biotechnology Other subject
29 Nov 2018
07:17 CET ESPERITE
Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates.
Biotechnology Other subject
27 Nov 2018
18:26 CET ESPERITE
ESPERITE N.V. convenes Annual General Meeting of Shareholders
Biotechnology Other subject
23 Nov 2018
23:35 CET ESPERITE
ESPERITE (ESP): financial results for 2017 are published.
Biotechnology Other subject

DeZwarteRidder
1
DeZwarteRidder
0
Company press releases
Displaying 41 - 60 of 110 results
Released Company Title Industry Topic
19 Nov 2018
15:35 CET ESPERITE
ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
Biotechnology Other subject
09 Nov 2018
07:17 CET ESPERITE
ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
Biotechnology Other subject
07 Nov 2018
07:17 CET ESPERITE
Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
Biotechnology Other subject
06 Nov 2018
08:56 CET ESPERITE
Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia.
Biotechnology Other subject
15 Oct 2018
07:17 CEST ESPERITE
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
Biotechnology Other subject
03 Oct 2018
18:18 CEST ESPERITE
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
Biotechnology Other subject
13 Sep 2018
07:17 CEST ESPERITE
ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
Biotechnology Other subject
31 Aug 2018
07:17 CEST ESPERITE
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
Biotechnology Other subject
29 Aug 2018
07:17 CEST ESPERITE
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
Biotechnology Other subject
15 Aug 2018
07:17 CEST ESPERITE
Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
Biotechnology Other subject
18 Jul 2018
08:26 CEST ESPERITE
Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
Biotechnology Other subject
02 Jul 2018
07:17 CEST ESPERITE
ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).
Biotechnology Other subject
28 Jun 2018
07:17 CEST ESPERITE
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today
Biotechnology Other subject
19 Jun 2018
07:17 CEST ESPERITE
Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
Biotechnology Other subject
18 Jun 2018
22:24 CEST ESPERITE
ESPERITE (ESP) further delays publication of Annual Report 2017.
Biotechnology Other subject
12 Jun 2018
07:17 CEST ESPERITE
European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
Biotechnology Other subject
06 Jun 2018
08:26 CEST ESPERITE
ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
Biotechnology Other subject
05 Jun 2018
07:17 CEST ESPERITE
ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
Biotechnology Other subject
17 May 2018
14:33 CEST ESPERITE
Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.
Biotechnology Other subject
17 May 2018
07:17 CEST ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today
Biotechnology Other subject
DeZwarteRidder
0
Company press releases
Displaying 61 - 80 of 110 results
Released Company Title Industry Topic
16 May 2018
09:31 CEST ESPERITE
ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION
Biotechnology Other subject
03 May 2018
11:36 CEST ESPERITE
Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke
Biotechnology Other subject
30 Apr 2018
12:55 CEST ESPERITE
ESPERITE NV (ESP) delays publication of Annual Report 2017
Biotechnology Other subject
11 Apr 2018
07:17 CEST ESPERITE
ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.
Biotechnology Other subject
29 Mar 2018
09:15 CEST ESPERITE
Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases
Biotechnology Other subject
02 Mar 2018
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today
Biotechnology Other subject
16 Feb 2018
07:17 CET ESPERITE
ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.
Biotechnology Other subject
31 Jan 2018
13:26 CET ESPERITE
ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.
Biotechnology Other subject
31 Jan 2018
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today
Biotechnology Other subject
16 Jan 2018
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today
Biotechnology Other subject
10 Jan 2018
15:07 CET ESPERITE
ESPERITE (ESP) : transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs
Biotechnology Other subject
10 Jan 2018
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today
Biotechnology Other subject
08 Jan 2018
12:59 CET ESPERITE
ESPERITE (ESP): CEO Frederic Amar converts a portion of his Loan Note into 1.5 million shares.
Biotechnology Other subject
05 Jan 2018
10:56 CET ESPERITE
ESPERITE (ESP): issues EUR 400'000 convertible note for additional financing provided by CEO Frederic Amar
Biotechnology Other subject
22 Dec 2017
07:17 CET ESPERITE
ESPERITE (ESP): EUR 1 million of new funding provided by European Select Growth Opportunities Fund until February 23, 2018
Biotechnology Other subject
17 Nov 2017
08:19 CET ESPERITE
ESPERITE N.V. (ESP) , Stabilisation before growth.
Biotechnology Other subject
09 Nov 2017
08:54 CET ESPERITE
ESPERITE (ESP) : L1 Capital invests for total EUR 500K today by subscribing to the Tenth tranche (EUR 250K) and shows confidence by investing additionally EUR 250K under the same conditions.
Biotechnology Other subject
09 Nov 2017
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions.
Biotechnology Other subject
30 Oct 2017
07:17 CET ESPERITE
ESPERITE (ESP) : L1 Capital subscribes to the Ninth tranche of investment today
Biotechnology Other subject
10 Oct 2017
08:52 CEST ESPERITE
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
Biotechnology Other subject
DeZwarteRidder
0
Company press releases
Displaying 81 - 100 of 110 results
Released Company Title Industry Topic
10 Oct 2017
07:17 CEST ESPERITE
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
Biotechnology Other subject
02 Oct 2017
07:17 CEST ESPERITE
ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions.
Biotechnology Other subject
29 Sep 2017
21:16 CEST ESPERITE
ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting
Biotechnology Other subject
31 Aug 2017
07:17 CEST ESPERITE
ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today
Biotechnology Other subject
11 Aug 2017
07:17 CEST ESPERITE
ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
Biotechnology Other subject
05 Jul 2017
07:17 CEST ESPERITE
ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today
Biotechnology Other subject
15 Jun 2017
07:17 CEST ESPERITE
ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today
Biotechnology Other subject
01 Jun 2017
07:17 CEST ESPERITE
ESPERITE (ESP): L1 Capital subscribes to the second packed tranche today, ahead of schedule
Biotechnology Other subject
31 May 2017
08:52 CEST ESPERITE
ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
Biotechnology Other subject
31 May 2017
08:26 CEST ESPERITE
ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
Biotechnology Other subject
31 May 2017
07:57 CEST ESPERITE
ESPERITE (ESP) Q1 consolidated revenue higher compared to budget
Biotechnology Other subject
31 May 2017
07:17 CEST ESPERITE
ESPERITE (ESP) has concluded new agreements with its note holders
Biotechnology Other subject
23 May 2017
15:44 CEST ESPERITE
ESPERITE N.V. convenes Annual General Meeting of Shareholders
Biotechnology Other subject
23 May 2017
07:17 CEST ESPERITE
ESPERITE (ESP) financial results for 2016 published
Biotechnology Other subject
20 May 2017
18:28 CEST ESPERITE
Esperite further delays publication of 2016 Annual Report
Biotechnology Other subject
19 May 2017
13:20 CEST ESPERITE
Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court
Biotechnology Other subject
15 May 2017
10:17 CEST ESPERITE
Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
Biotechnology Other subject
15 May 2017
10:17 CEST ESPERITE
Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
Biotechnology Other subject
15 May 2017
07:17 CEST ESPERITE
Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
Biotechnology Other subject
15 May 2017
07:17 CEST ESPERITE
Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
Biotechnology Other subject
DeZwarteRidder
0
Company press releases
Displaying 101 - 110 of 110 results
Released Company Title Industry Topic
11 May 2017
09:27 CEST ESPERITE
Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology
Biotechnology Other subject
05 May 2017
09:08 CEST ESPERITE
Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy
Biotechnology Other subject
26 Apr 2017
07:17 CEST ESPERITE
ESPERITE delays publication of 2016 Annual Report
Biotechnology Other subject
25 Apr 2017
07:17 CEST ESPERITE
ESPERITE N.V. (ESP) WITH CRYOSAVE CONTRIBUTES TO TREATING A 9 YEAR OLD CHILD WITH THALASSEMIA MAJOR IN SWITZERLAND
Biotechnology Other subject
24 Apr 2017
07:17 CEST ESPERITE
ESPERITE's shareholders approved the external financing of up to EUR 13 million
Biotechnology Other subject
31 Mar 2017
22:06 CEST ESPERITE
CryoSave e Crioestaminal chegaram a um acordo para a armazenagem das células estaminais da Bioteca
Biotechnology Other subject
10 Mar 2017
14:29 CET ESPERITE
Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million
Biotechnology Other subject
08 Mar 2017
08:26 CET ESPERITE
Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
Biotechnology Other subject
08 Mar 2017
07:17 CET ESPERITE
Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
Biotechnology Other subject
28 Feb 2017
08:55 CET ESPERITE
Esperite N.V.: Update on Financing
Biotechnology Other subject
Amarillo
0
DeZwarteRidder
1
quote:

Amarillo schreef op 5 augustus 2020 15:13:


Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn

Slimme mensen leren van het verleden.

Iemand die deze berichten goed leest begrijpt dat hij wordt opgelicht.

Ik wil newbies een eerlijke kans geven om hun geld al dan niet weg te gooien.
Amarillo
0
Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst
DeZwarteRidder
0
quote:

Amarillo schreef op 6 augustus 2020 07:34:


Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst

Dat geldt natuurlijk ook voor jou met je opschepperij.
Amarillo
0
We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??
DeZwarteRidder
1
quote:

Amarillo schreef op 6 augustus 2020 08:45:


We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??

Het is opvallend maar niet verbazingwekkend dat jij nooit ingaat op inhoudelijke zaken m.b.t. Esperite.

Gelukkig kun je nog terecht in Benidorm, want daar kunnen ze altijd proppers gebruiken.
DeZwarteRidder
0
quote:

Amarillo schreef op 10 augustus 2020 16:47:


Gelukkig vetrouwd ridder blind op dubieuze geert..

Ik heb helemaal niks met Geert, zelfs geen abonnement.
14 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 3 dec 2021 17:35
Koers 0,024
Verschil +0,000 (+0,42%)
Hoog 0,024
Laag 0,022
Volume 409.728
Volume gemiddeld 280.501
Volume gisteren 231.228

Brussel real time stocks quotedata by Euronext. Other real time EU stocks, by Cboe Europe Ltd.; US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront